Skip to main content
Ajay Verma, MD, Oncology, Redding, CA

Ajay K Verma MD


Physician

Join to view full profile
  • 1555 East StSuite 230Redding, CA 96001

  • Phone+1 530-244-7400

  • Fax+1 530-244-7800

Dr. Verma is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • SUNY Downstate Health Sciences University
    SUNY Downstate Health Sciences UniversityFellowship, Hematology and Medical Oncology, 1986 - 1987
  • NYC Health & Hospitals/South Brooklyn Health
    NYC Health & Hospitals/South Brooklyn HealthFellowship, Hematology, 1984 - 1986
  • Icahn School of Medicine at Mount Sinai (North General)
    Icahn School of Medicine at Mount Sinai (North General)Residency, Internal Medicine, 1983 - 1984
  • BronxCare Health System
    BronxCare Health SystemResidency, Internal Medicine, 1981 - 1983
  • Delhi University College of Medical Sciences
    Delhi University College of Medical SciencesClass of 1979

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1987 - 2025
  • NY State Medical License
    NY State Medical License 1985 - 2017
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification iKnowMed Generation 2, McKesson, 2016-2017

Press Mentions

  • Triple Nucleophilic Head-to-Tail Cascade Polycyclization of Diazodienals via Combination Catalysis: Direct Access to Cyclopentane Fused Aza-Polycycles with Six-Contiguous Stereocenters
    Triple Nucleophilic Head-to-Tail Cascade Polycyclization of Diazodienals via Combination Catalysis: Direct Access to Cyclopentane Fused Aza-Polycycles with Six-Contiguous StereocentersJune 24th, 2024
  • Yumanity Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Developments
    Yumanity Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate DevelopmentsAugust 12th, 2021
  • Yumanity Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Developments
    Yumanity Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate DevelopmentsMay 13th, 2021

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: